Form 4 Filing for Zelnick Kaufman Beth

This filing details a transaction by Zelnick Kaufman Beth, Chief Legal Officer of CorMedix Inc. On August 29, 2026, Ms. Kaufman disposed of 8,424 shares of CorMedix Inc. common stock at a price of $8.30 per share. Following this transaction, Ms. Kaufman directly owns 260,684 shares of CorMedix Inc. common stock. The transaction was reported on Form 4 and was not subject to Section 16 reporting requirements.